Regulation of Gut Microbiota on Immune Reconstitution in Patients With Acquired Immunodeficiency Syndrome

Bibliographic Details
Title: Regulation of Gut Microbiota on Immune Reconstitution in Patients With Acquired Immunodeficiency Syndrome
Authors: Shi-Tao Geng, Zun-Yue Zhang, Yue-Xin Wang, Danfeng Lu, Juehua Yu, Jian-Bo Zhang, Yi-Qun Kuang, Kun-Hua Wang
Source: Frontiers in Microbiology, Vol 11 (2020)
Publisher Information: Frontiers Media S.A., 2020.
Publication Year: 2020
Collection: LCC:Microbiology
Subject Terms: HIV/AIDS, gut microbiota, immune reconstitution, probiotics, fecal bacteria transplantation, Microbiology, QR1-502
More Details: Human immunodeficiency virus type 1 (HIV-1) infection of CD4+ T cells in the gut plays an insidious role in acquired immunodeficiency syndrome (AIDS) pathogenesis. Host immune function is closely related to gut microbiota. Changes in the gut microbiota cause a different immune response. Previous studies revealed that HIV-1 infection caused changes in gut microbiota, which induced immune deficiency. HIV-1 infection results in an abnormal composition and function of the gut microbiota, which may disrupt the intestinal epithelial barrier and microbial translocation, leading to long-term immune activation, including inflammation and metabolic disorders. At the same time, an abnormal gut microbiota also hinders the effect of antiviral therapy and affects the immune reconstruction of patients. However, studies on the impact of the gut microbiota on immune reconstitution in patients with HIV/AIDS are still limited. In this review, we focus on changes in the gut microbiota caused by HIV infection, as well as the impact and regulation of the gut microbiota on immune function and immune reconstitution, while we also discuss the potential impact of probiotics/prebiotics and fecal microbiota transplantation (FMT) on immune reconstitution.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-302X
Relation: https://www.frontiersin.org/articles/10.3389/fmicb.2020.594820/full; https://doaj.org/toc/1664-302X
DOI: 10.3389/fmicb.2020.594820
Access URL: https://doaj.org/article/e0ebc8756bee4ea199f9c3aef261ebaa
Accession Number: edsdoj.0ebc8756bee4ea199f9c3aef261ebaa
Database: Directory of Open Access Journals
More Details
ISSN:1664302X
DOI:10.3389/fmicb.2020.594820
Published in:Frontiers in Microbiology
Language:English